Rationale and design of the African group A streptococcal infection registry : the AFROStrep study

Barth, Dylan D. ; Engel, Mark E. ; Whitelaw, Andrew ; Alemseged, Abdissa ; Sadoh, Wilson E. ; Ali, Sulafa K. M. ; Sow, Samba O. ; Dale, James ; Mayosi, Bongani M (2016)

CITATION: Barth, D. D., et al. 2016. Rationale and design of the African group A streptococcal infection registry : the AFROStrep study, BMJ Open, 6:e010248, doi:10.1136/bmjopen-2015-010248.

The original publication is available at http://bmjopen.bmj.com


Introduction: Group A β-haemolytic Streptococcus (GAS), a Gram-positive bacterium, also known as Streptococcus pyogenes, causes pyoderma, pharyngitis and invasive disease. Repeated GAS infections may lead to autoimmune diseases such as acute post-streptococcal glomerulonephritis, acute rheumatic fever (ARF) and rheumatic heart disease (RHD). Invasive GAS (iGAS) disease is an important cause of mortality and morbidity worldwide. The burden of GAS infections is, however, unknown in Africa because of lack of surveillance systems. Methods and analysis: The African group A streptococcal infection registry (the AFROStrep study) is a collaborative multicentre study of clinical, microbiological, epidemiological and molecular characteristics for GAS infection in Africa. The AFROStrep registry comprises two components: (1) active surveillance of GAS pharyngitis cases from sentinel primary care centres (non-iGAS) and (2) passive surveillance of iGAS disease from microbiology laboratories. Isolates will also be subjected to DNA isolation to allow for characterisation by molecular methods and cryopreservation for long-term storage. The AFROStrep study seeks to collect comprehensive data on GAS isolates in Africa. The biorepository will serve as a platform for vaccine development in Africa. Ethics and dissemination: Ethics approval for the AFROStrep registry has been obtained from the Human Research Ethics Committee at the University of Cape Town (HREC/REF: R006/2015). Each recruiting site will seek ethics approval from their local ethics’ committee. All participants will be required to provide consent for inclusion into the registry as well as for the storage of isolates and molecular investigations to be conducted thereon. Strict confidentiality will be applied throughout. Findings and updates will be disseminated to collaborators, researchers, health planners and colleagues through peer-reviewed journal articles, conference publications and proceedings.

Please refer to this item in SUNScholar by using the following persistent URL: http://hdl.handle.net/10019.1/102042
This item appears in the following collections: